Results 131 to 140 of about 170,520 (332)
Abstract Purpose The demand for specialised eye care has quadrupled over the last two decades, driven by an aging population and the advent of new treatments. This surge has led to increased outsourcing by the Helsinki and Uusimaa Hospital District (HUS) Eye Hospital, initially relying on a fee‐for‐service model. This model, however, has been marked by
Susanna Moisander +7 more
wiley +1 more source
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin [PDF]
Neil M. Bressler
openalex +1 more source
Expanding the Interface: Overlooked Dermatologic Disorders With Ocular Involvement
JEADV Clinical Practice, EarlyView.
A George
wiley +1 more source
Progression and topographic subtypes of Terrien marginal degeneration
Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila +8 more
wiley +1 more source
Potential role of lampalizumab for treatment of geographic atrophy
William Rhoades, Drew Dickson, Diana V Do Truhlsen Eye Institute, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE, USA Abstract: The purpose of this article is to review the pathways underlying age ...
Rhoades W, Dickson D, Do DV
doaj
Treatment efficacy for age-related macular degeneration relies on early diagnosis and precise determination of the disease stage. This involves analyzing biomarkers in retinal images, which can be challenging when handling a large flow of patients and ...
Ekaterina A. Lopukhova +6 more
doaj +1 more source
The Psychosocial Impact of Macular Degeneration [PDF]
Rebecca Williams
openalex +1 more source
Abstract Purpose To evaluate test–retest variability (TRV) of the full‐field stimulus test (FST) in patients with retinitis pigmentosa (RP) and poor best‐corrected visual acuity (BCVA; ≤20/50 Snellen; ≥0.40 logMAR), and to assess the reliability of FST as a clinical endpoint in future RP trials.
J. S. Karuntu +2 more
wiley +1 more source
Neovascular age-related macular degeneration is a progressive, blinding macular disease that has become a burden both in healthcare systems and the global economy. The vascular endothelial growth factor (VEGF) is the main agent involved in the pathogenic
Andreea Dana Moraru +5 more
doaj +1 more source

